$QLYS

Berquist Thomas sold $104K of QLYS

Berquist Thomas sold 939 shares of QUALYS, INC. (QLYS) at $110.75 ($0.10M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Berquist Thomas
Published Jun 15, 2026, 8:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QLYS
Neutral
high confidence
Mentioned
$QLYS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QLYSNeutralLow
01

Why it matters

A director’s open-market sale under a pre-arranged 10b5-1 plan is generally treated as routine compliance rather than a new fundamental catalyst.

02

Market read

Traders may note the filing for positioning/sentiment, but there is no new company-specific information to drive repricing.

03

What to watch

The article provides only the sale size and plan type; it doesn’t indicate whether other insiders bought, whether the sale was tax-related, or whether there were concurrent operational updates.

Relevance 3/10Novelty 2/10Timing: SEC Form 4 filed today (2026-06-15) disclosing a 2026-06-12 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Qualys, Inc.

Company-level read

Ticker impact

$QLYSNeutralHigh confidence
Context

Qualys Form 4 shows director Berquist Thomas sold 939 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and short-lived.

Evidence & confidence

The filing is an insider sale (not a buy), explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific operational or guidance change.

Market effects

No sector read-through; this is a single-company insider transaction without new regulatory/product/earnings information.

None.

None.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with private views on valuation or liquidity needs; traders may still watch for follow-on selling.

Key entities

  • QUALYS, INC.

    Company whose shares were sold by a director via an open-market transaction under a 10b5-1 plan.

  • Berquist Thomas

    Director who sold 939 shares at $110.75/share; holdings after sale were 6,781 shares.

Related articles

$QLYSMedAI 8/10

Qualys, Inc. Q2 2026 Earnings Call Summary

Qualys reported Q2 2026 earnings call updates focused on AI-driven threat acceleration and shifting bottlenecks from detection to remediation. Management raised full-year 2026 revenue guidance to $732 million–$738 million, assuming ~105% net dollar expansion. It cited 22% channel-led growth, 54% of revenue from partners, and $76.8 million in Q2 buybacks. Qualys also highlighted FedRAMP High and CISA 72-hour remediation mandates.

$QLYSHighAI 9/10

Why Qualys Stock Crushed it on Wednesday

Qualys (NASDAQ: QLYS) reported Q2 results before market open, posting revenue of about $182.2M, up 11% year over year, and non-GAAP net income above $69M, up 13% to $1.98 per share. The company cited sustained demand and AI-enhanced offerings. Guidance for Q3 and FY2026 included revenue and adjusted EPS targets that beat consensus, and shares rose nearly 14% on the day.